Abstract:β‐Arrestins are implicated in desensitization of activated G protein‐coupled receptors (GPCRs) and transduction of signals in their own right. Biased ligands possessing different efficacies in activating different G protein‐dependent and β‐arrestin‐dependent signals downstream of a single GPCR have been described. Here, we report the characterization of agonist bias for compounds developed along a drug discovery project of β2‐adrenoceptor agonists. Compounds, including derivatives of fenoterol, 2‐amino‐1‐phenylethanol and 2‐amino‐2‐phenylethanol, were obtained or synthesized and their effects on cardiomyocyte contractility, cAMP synthesis and β‐arrestin recruitment were determined in β2‐adrenoceptor‐expressing cells. Gs versus β‐arrestin bias were analyzed by the operational model. Gs versus Gs/Gi bias were studied by means of sensitivity towards pertussis toxin, a Gi disruptor. Three compounds with a core structure of 5‐(1‐amino‐2‐hydroxyethyl)‐8‐hydroxyquinolin‐2(1H)‐one were identified as β‐arrestin‐biased β2‐adrenoceptor agonists. These findings would facilitate the development of novel drugs for the treatment of heart failure and asthma.Support or Funding InformationThis work was supported by the Ministry of Science and Technology of the People's Republic of China under the National Key Research and Development Program of China [2018YFA0507603], the National Science and Technology Major Project [2013ZX09507001‐001002, 2013ZX09301305‐001, 2013ZX09508104, 2018ZX09739009], the National Basic Research Program [2012CB518000], the National Natural Science Foundation of China [81673355, 81872752, 31521062, 81630008, 81790621], Beijing Municipal Science & Technology Commission [Z171100000417006], and the intramural research program of the NIH, USA.This abstract is from the Experimental Biology 2019 Meeting. There is no full text article associated with this abstract published in The FASEB Journal.

Studies on the Interactions Between Β2adrenergic Receptor and Gs Protein by Molecular Dynamics Simulations

Exploring the Deactivation Mechanism of Human Β2 Adrenergic Receptor by Accelerated Molecular Dynamic Simulations

Analysis of β2AR-Gs and β2AR-Gi complex formation by NMR spectroscopy.

Universal Properties and Specificities of the β2-Adrenergic Receptor-Gs Protein Complex Activation Mechanism Revealed by All-Atom Molecular Dynamics Simulations

Early Events in β2AR Dimer Dynamics Mediated by Activation-Related Microswitches

Different conformational responses of the β2-adrenergic receptor-Gs complex upon binding of the partial agonist salbutamol or the full agonist isoprenaline

Conformational changes in the G protein Gs induced by the β2 adrenergic receptor

Structures of β1-adrenergic receptor in complex with Gs and ligands of different efficacies

Evolutionary Trace and Molecular Dynamics Simulation of the Beta2 Adrenergic Receptor Mutation-induced Activation

Analysis of <sub>2</sub>AR-G<sub>s</sub> and <sub>2</sub>AR-G<sub>i</sub> complex formation by NMR spectroscopy

Structure of a nanobody-stabilized active state of the β2 adrenoceptor

Conformational Transitions and Activation of the Adhesion Receptor CD97.

Molecular Mechanism of Action of GPR91 Agonists and Antagonists: Insights from Molecular Dynamics Simulation

Allosteric Effect of Nanobody Binding on Ligand-Specific Active States of the β2 Adrenergic Receptor

A New Series of Gs‐ and Β‐arrestin‐biased Β2‐adrenoceptor Agonists

Effects of Ligand Binding on the Mechanical Stability of Protein GB1 Studied by Steered Molecular Dynamics Simulation

Distinct binding conformations of epinephrine with α- and β-adrenergic receptors

Cryo-EM Structures of Inactive and Gi-coupled GABAB Heterodimer

Visualizing the M2 muscarinic acetylcholine receptor activation regulated by aromatic ring dynamics

Structural basis of α 1A -adrenergic receptor activation and recognition by an extracellular nanobody

Analysis of Β 2 AR-G S and Β 2 AR-G I Complex Formation by NMR Spectroscopy